eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | b-cell lymphomas |
| Comorbidity | C0019196|hepatitis c |
| Sentences | 8 |
| PubMedID- 20823454 | Hepatic toxicity and prognosis in hepatitis c virus-infected patients with diffuse large b-cell lymphoma treated with rituximab-containing chemotherapy regimens: a japanese multicenter analysis. |
| PubMedID- 23465418 | Early-stage splenic diffuse large b-cell lymphoma is highly associated with hepatitis c virus infection. |
| PubMedID- 24270404 | Outcome prediction of diffuse large b-cell lymphomas associated with hepatitis c virus infection: a study on behalf of the fondazione italiana linfomi. |
| PubMedID- 25899771 | Prognostic impact of hepatitis c virus infection in patients with diffuse large b-cell lymphoma treated with immunochemotherapy in the context of a novel prognostic index. |
| PubMedID- 22736295 | Clinical outcome in diffuse large b-cell lymphoma with hepatitis c virus infection in the rituximab era: a single center experience. |
| PubMedID- 24060287 | Bendamustine and rituximab for indolent b-cell non-hodgkin lymphoma in patients with compensated hepatitis c cirrhosis: a case series. |
| PubMedID- 22395482 | b-cell lymphoma in hepatitis c virus (hcv)-seropositive patients frequently presents with extranodal disease in the bone marrow, major salivary glands, or spleen [1, 2]. |
| PubMedID- 25381127 | The notch pathway is recurrently mutated in diffuse large b-cell lymphoma associated with hepatitis c virus infection. |
Page: 1